This inventor holds 30 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 4 EPO patents, primarily in Nanocrystals and Compositions. Top assignees: Johns Hopkins University, Kala Pharmaceuticals, Inc., Alcon, Inc.. Active years: 2012-2024.
Company Filing History:
21 out of 3,798 
9 out of 53 
1 out of 1,306 
Years Active: 2012-2024
Areas of Expertise:
Title: The Innovative Contributions of Alexey Popov in Pharmaceutical Science
Introduction: Alexey Popov, based in Waltham, MA, has made significant strides in the field of pharmaceutical science with an impressive portfolio of 30 patents. His work primarily focuses on developing compositions and methods that enhance particle transport through mucus barriers, which is critical for effective drug delivery systems.
Latest Patents: Among his latest innovations, Popov has patented several compositions and methods associated with nanocrystals that facilitate particle transport in mucus. These innovations include creating mucus-penetrating particles (MPP) without polymeric carriers or using minimal amounts of such carriers. His patented methods involve modifying surface coatings of pharmaceutical agents that display low water solubility. This research holds promise for a variety of applications, including drug delivery, imaging, and diagnostics. Notably, his pharmaceutical compositions are tailored for routes that necessitate passage through mucosal barriers, proving useful in both general and ophthalmic applications.
Career Highlights: Throughout his career, Alexey Popov has collaborated with renowned institutions, notably The Johns Hopkins University and Kala Pharmaceuticals, Inc. His work at these organizations has significantly influenced the landscape of pharmaceutical innovations, especially in overcoming challenges faced in drug transport across biological barriers.
Collaborations: Popov has worked alongside esteemed colleagues such as Elizabeth M. Enlow and James Bourassa. Their combined expertise has greatly contributed to advancements in the methodologies and applications of particle transport in pharmaceutical sciences.
Conclusion: Alexey Popov's extensive patent portfolio and impactful collaborations underscore his commitment to advancing the field of drug delivery mechanisms. His innovations not only enhance the effectiveness of pharmaceutical agents but also pave the way for innovative solutions to complex medical challenges. As research continues to evolve, the contributions of inventors like Popov remain vital in shaping the future of healthcare and medicine.